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1. Introduction 
Silicosis is known as environmental and occupational pulmonary fibrosis and the most typical 
form of pneumoconiosis results from long-term exposure (ten years or more) to relatively low 
concentrations of silica dust and usually appears ten to thirty years after the first exposure 
(Hoffman & Wanderer, 2010; Madl, 2008; Rimal, 2005). Patients with this type of silicosis, 
especially in the early stages, may not have obvious signs or symptoms of disease, but 
abnormalities may be detected by x-ray. Chronic cough and exertional dyspnea are common 
clinical findings. Radiographically, chronic simple silicosis reveals a profusion of small (less 
than 10 mm in diameter) opacities, typically rounded, and predominating in the upper lung 
zones. Patients with silicosis are particularly susceptible to tuberculosis infection—known as 
silicotuberculosis (Brown, 2009). It is thought that silica damages pulmonary macrophages, 
inhibiting their ability to kill mycobacteria. Pulmonary complications of silicosis also include 
chronic bronchitis and airflow limitation, non-tuberculous Mycobacterium infection, fungal 
lung infection, compensatory emphysema, and pneumothorax (Cohe & Velho, 2002; Rees & 
Murray, 2007). Lung cancer is also considered to be associated with silicosis and the 
International Agency for Research on Cancer (IARC) categorized crystalline silica as a 
causative of lung cancer (Cocco, 2007; IARC, 1997; Pelucchi, 2006). In addition, it is well known 
that silicosis patients (SILs) often experience complications due to autoimmune diseases 
(Shanklin & Smalley, 1998; Steenland & Goldsmith, 1995; Uber & McReynolds, 1982) such as 
rheumatoid arthritis (known as Caplan syndrome) (Caplan, 1959, 1962), systemic lupus 
erythematosus (SLE) (Bartsch, 1980; Yamazaki 2007), systemic scleroderma (SSc) (Barnadas, 
1986; Cowie, 1987 Haustein, 1990; Haustein & Anderegg, 1998; Sluis-Cremer, 1985) and anti-
neutrophil cytoplasmic autoantibody (ANCA)-related vasculitis/nephritis (Bartůnková, 2006; 
Mulloy, 2003; Tervaert, 1998). 
Silica-induced dysregulation of autoimmunity has been thought to be caused by the 
adjuvant effect of silica (Cooper, 2008; Davis, 2001, Parks, 1999). Although this represents 
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one mechanism by which silica might be involved in the development of autoimmune 
diseases, silica can influence circulating immunocompeting cells and dysregulate the T 
responder (Tresp) survival and activation status, since several different autoimmune 
diseases may be associated with silica dust exposure as mentioned above. In addition, silica 
may affect the regulatory T cell (Treg, CD4+25+FoxP3+), since Treg has been considered the 
most important subpopulation of T cells for the control of Tresp activation by the 
recognition of foreign and/or auto-antigens (Baecher-Allan, 2004; Bluestone & Tang, 2005; 
Schwartz, 2005). If the function or number of Treg is reduced, continuous stimulation of 
Tresp is thought to be maintained. 
Furthermore, recent findings regarding the NOD-like receptor family, pryin domain 
containing 3 (NLRP3, Nalp3)-inflammasome, have contributed substantially to our 
understanding of the sequential cellular events occurring when silica is inhaled into the 
pulmonary region and alveolar macrophages try to treat silica particles as a foreign 
substance (Cassel, 2008; Dostert, 2008; Hormung, 2008). 
At first, initial recognition of silica occurs by cell membrane receptors such as the 
macrophage receptor with collagenous structure (MARCO), scavenger receptor (SR)-AI and 
SR-AII (Brown, 2007; Hamilton, 2006; Thakur, 2009). The next stage involves capture of silica 
by macrophages and entrapment within lysosomes and their activation of the nucleotide-
binding domain and leucine-rich repeat containing proteins, the NLRP3 inflammasome, to 
cleave pro-caspase 1 to an active form (Cassel, 2008; Dostert, 2008; Hormung, 2008). 
Thereafter, cleavage of pro-interleukin (IL)-1ǃ occurs to an active form for release to form 
fibrotic nodules and production of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) in the macrophages yielded (37-40). As a consequence, the induction of 
cellular and tissue damages occur due to the production of ROS and RNS and the apoptosis 
of alveolar macrophages. Various cytokines/chemokines such as IL-1ǃ，tumor necrosis 
factor (TNF)-ǂ, macrophage inflammatory protein (MIP)-1/2, monocyte-chemoattractant 
protein-1 (MCP-1) and IL-8 are produced that cause chronic inflammation and proliferation 
of collagenic fibers (Barrett, 1999; Hamilton, 2008; Hubbard, 2001; Porter, 2002). Silica 
particles are released from alveolar macrophages and the similar cellular reactions described 
above by newly-recognizing nearby macrophages will be repeated. Finally, silica particles 
are transferred to regional lymph nodes. As these cellular and molecular reactions are 
continuously repeated, pulmonary fibrosis will gradually and progressively appear. 
Even though details of these initial biological sequential reactions are recognized, it is still 
unclear how silica causes dysregulation of autoimmunity. From this viewpoint, we have 
been investigating the following perspectives: 
1. Alteration of Fas and related molecules to affect long-term survival of lymphocytes. 
2. Chronic activation of Tresp exposed to silica particles. 
3. Alteration of Treg function and/or numbers exposed to silica particles. 
In this chapter, we describe and summarize our experimental findings regarding the above 
three viewpoints, and insights concerning silica-induced dysregulation of autoimmunity 
will be discussed. Investigation using patient materials such as serum and lymphocytes 
were approved by the Institutional Ethics Committee of Kawasaki Medical School, Kusaka 
Hospital or Hinase-Urakami Iin. The specimens were only obtained from patients who gave 
documented informed consent. All of the patients were Japanese brickyard workers in Bizen 
City (Okayama prefecture, Japan), and were monitored at either Kusaka Hospital or the 
Hinase-Urakami Clinic. The silica in materials handled by these workers (e.g., dirt, sand, 
mud, concrete), and thus presenting the potential risk of being inhaled by these individuals 
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in their work environment, was estimated to reach levels as high as 40–60% (by mass). The 
subjects were diagnosed with pneumoconiosis according to the ILO 2000 Guideline (ILO, 
2004). These patients displayed neither clinical symptoms related to autoimmune diseases 
(e.g., sclerotic skin, Raynaud’s phenomenon, facial erythema, or arthralgia) nor any cancers.  
2. Alteration of Fas/CD95 and its related molecules in SILs 
The discovery of Fas has led to a remarkable improvement in our understanding of 
apoptosis and its signal transduction (Matiba, 1997; Nagata, 1996; Nagata & Golstein, 1995). 
Abnormal regulation of apoptosis, particularly in relation to the Fas/Fas ligand (FasL) 
pathway, has been thought to play a role in the pathogenesis of autoimmune diseases 
(Eguchi, 2001; Rudin, 1996; Yonehara, 2002). Mutations of the fas gene and the fas ligand gene 
which lead to defects in apoptosis have been found in autoimmune strains of mice (lpr mice 
and gld mice, respectively) and human autoimmune lymphoproliferative syndrome (ALPS) 
in childhood (Nagata, 1998; Nagata & Suda, 1995, Mountz & Edwards, 1992; Steinberg, 
1994). Fas/CD95, which is mainly expressed on the cell membrane of lymphocytes, usually 
exists as membrane-type Fas and forms a Fas-trimer after binding with FasL (Matiba, 1997; 
Nagata, 1996; Nagata & Golstein, 1995). The signal-transducing death domain located in the 
intracellular domain of Fas then recruits Fas-associated protein with Death Domain (FADD) 
and pro-caspase 8 to form the active death-inducing signaling complex (DISC) (Curtin & 
Cotter, 2003; Yu & Shi, 2008). Thereafter, activated caspase-8 triggers a caspase-cascade 
involving the activation of CAD/CPAN/DFF40 by removing its inhibitor, ICAD/DFF45, 
DNA fragmentation, and finally apoptotic cell death (Sabol, 1998; Sakahira, 1998). 
The most typical alternatively spliced variant of the wild-type fas gene transcript is known 
as soluble Fas (sFas). Since this variant transcript lacks 63 bp of the transmembrane domain, 
its product (sFas) can be secreted from cells to suppress membrane Fas-mediated apoptosis 
by blocking the binding between membrane Fas and the FasL in the extracellular region 
(Matiba, 1997; Nagata, 1996; Nagata & Golstein, 1995). If there is a high level of sFas in the 
extracellular regions, lymphocytes in these regions may avoid apoptosis and survive longer. 
Actually, there have been several studies showing elevated serum levels of sFas in patients 
with autoimmune diseases (Cheng, 1994; Knipping, 1995; Tokano, 1996).  
The following findings were obtained from our series of analyses of specimens from SILs. 
The detection of autoantibody to Fas and caspase-8, as well as topoisomerase I and 
desmoglein (Takata-Tomokuni, 2005; A. Ueki, 2001a, 2002; H. Ueki, 2001). Anti-Fas 
autoantibody detected in SILs was functionally active and caused Fas-mediated apoptosis 
(takata-Tomokuni, 2005). The level of serum sFas was higher in SILs than healthy volunteers 
(HVs), although the level of serum soluble FasL did not differ between SILs and HVs 
(Tomokuni, 1997, 1999). The mean fluorescent intensity (MFI) of membrane Fas was lower 
with lymphocytes from SILs than those from HVs, although total numbers of Fas-positive 
lymphocytes (membrane Fas expression) did not differ between the two populations 
(Otsuki, 2005). The weaker membrane Fas expressers (among lymphocytes) were identified 
to be weaker fas message expressers (Otsuki, 2005). The gene expression levels of 
extracellular inhibitor competing membrane Fas-FasL binding such as sFas, decoy receptor 3 
(DCR3), and other alternatively spliced variants of the fas gene were higher in peripheral 
blood mononuclear cells (PBMC) from SILs than HVs (Otsuki, 2000a, 2000b). The 
intracellular apoptosis-inhibitory genes including i-flice, sentrin, survivine and icad showed a 
lower expression in PBMC from SILs than HDs (Guo, 2001; Otsuki, 2000c).  
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Although significant mutations of fas and fas ligand genes were not detected, these results 
indicated that two populations of lymphocytes may exist in the peripheral blood of SILs. As 
shown on the right side of Fig. 1, one population is a weaker membrane Fas expresser and 
these cells may have developed out of an excessive transcription of the alternatively spliced 
fas gene and other variant messages. Therefore, these cells may be resistant to the functional 
anti-fas autoantibody, secrete higher levels of sFas, DCR3 and spliced variants, and are 
resistant to Fas-mediated apoptosis (Murakami, 2007, Otsuki, 2005, 2007). As reported 
previously (Otsuki, 2005), patients with a weaker MFI of membrane Fas often have a higher 
titer of anti-nuclear antibodies (ANA), and self-recognizing clones in silicosis may be 
included in the fraction because these clones may survive longer and show resistance to 
apoptosis.  
The other population, shown on the left side of Fig. 1, represents stronger membrane Fas 
expressers that may be sensitive to Fas-mediated apoptosis including cell death caused by 
anti-Fas autoantibody, show a reduced expression of intracellular inhibitor genes of Fas-
mediated apoptosis, and undergo apoptosis. These cells may be recruited from bone 
marrow after reaching the final stage of cell death. This recruited fraction would not have 
encountered silica and would be sensitive to Fas-mediated apoptosis. As a result, cells in 
this fraction would be continuously undergoing renewal and then apoptosis (Murakami, 
2007, Otsuki, 2005, 2007). 
The overall findings support the supposition that the long-term surviving subpopulation of 
T cells may include self-recognizing clones. However, these results provide no evidence that 
the lymphocytes in SILs are activated continuously. Thus, an investigation that incorporates 
experimental and patient-oriented studies is required to observe the chronic activation of 
Tresp by silica. 
3. Chronic activation of Tresp by exposure to silica 
To investigate the hypothesis that silica chronically activates Tresp, we first examined the in 
vitro activation of Tresp by exposure to silica (Wu, 2005). Freshly isolated PBMCs from HVs 
were cultured with or without phytohaemagglutinin (PHA), Min-U-silica (25 or 50 µg/ml) 
or chrysotile A (an asbestos, 50 µg/ml) for ten days. The expression of CD69 was used as the 
marker for early activation of T cells. Results showed that only silica can upregulate CD69 
expression in T cells slowly and gradually in a dose-dependent manner in regard to cell 
surface expression (as shown in Fig. 2-A) and the message level (Wu, 2005). Although the 
data is not shown here, it was evident that PHA can stimulate T cells and that CD69 
expression was observed at day 1 as the peak and then gradually reduced until day 5 (Wu, 
2005). Additionally, chrysotile A was not able to induce CD69 expression (Wu, 2005). In this 
study, the necessity of the existence of phagocytosed cells in contact with lymphocytes was 
also found, and soluble factors secreted from phagocytosed cells contributed to 
approximately half of the induced CD69 expression in T cells (Wu, 2005). These results 
indicated the importance of the NLRP3 inflammasome in these experimental situations. 
Moreover, if Tresp in SILs encounter silica at the pulmonary circulation and also regional 
lymph nodes where silica is accumulated after it is handled by alveolar macrophages, they 
can be exposed to silica chronically and recurrently. In view of this consideration, the 
activation of Tresp in circulating peripheral blood Tresp and collateral evidence of Tresp 
activation were then investigated. 
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Fig. 1. Schematic model of the dysregulation of Fas and Fas-related molecules found in 
patients with silicosis. Two groups (temporarily designated T cell - i – and - ii -) may exist 
among lymphocytes from these patients: a population repeatedly undergoing apoptosis 
caused by silica and recruited from bone marrow, and another population surviving in the 
long term by avoiding apoptosis due to self-producing inhibitory molecules such as soluble 
Fas that may include self-recognizing clones. 
With the recent recognition of Treg, most of the peripheral CD4+25+ T cells, particularly the 
higher expresser of CD25, are considered as Treg (Baecher-Allan, 2004; Bluestone & Tang, 
2005; Schwartz, 2005). However, activated Tresp also express CD25 on their surface. 
Although Treg is defined in regard to the nuclear forkhead box P3 (FoxP3) gene as the 
master gene of Treg to manifest Treg function in order to inhibit the Tresp activation 
response against auto, foreign, cancerous and transplanted antigens (Baecher-Allan, 2004; 
Bluestone & Tang, 2005; Schwartz, 2005), observation of FoxP3 expression by flow 
cytometry requires the permeabilization of cell surface and nuclear membranes. This 
procedure is not suitable for subsequent biological examinations using sorted cells. Thus, in 
the following experiments, CD4+25+ cells were sorted to examine gene expression and the 
inhibitory function of the fraction.  
As the marker for activation, we again used CD69 as an early activation marker and 
programmed cell death-1 (PD-1) genes (Saresella, 2008; Wang, 2009). Peripheral blood 
CD4+25- and CD4+25+ cells derived from HVs or SILs were collected by flow cytometry 
and relative gene expressions of CD69 and PD-1 were analyzed by real-time RT-PCR in 
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comparison to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression (Hayashi, 
2010). As shown in Fig. 2-B, the CD4+25- fraction from both HVs and SILs revealed a higher 
expression of CD69 than CD25+ cells. In addition, CD69 expression in the CD25- fraction of 
SILs was significantly higher than that of HVs. Furthermore, as shown in Fig. 2-C, the 
expression of PD-1 was higher in the CD25- and CD25+ fractions of SILs than HVs. These 
findings supported the view that Tresp in SILs were chronically and recurrently activated 
and possessed long-term survival. Since CD69 expression was limited in the early stage of T 
cell activation, it is significant that the CD25+ fraction from both populations showed lower 
expression. However, both the CD25- and CD25+ fractions showed a higher expression of  
 
 
Fig. 2. Various examinations to recognize the effects of silica exposure on responder T cells 
(Tresp). ＊：p<0.05, ＊＊<0.01 and ▲：0.05<p<0.1. [A] Peripheral blood mononuclear cells 
from healthy volunteers (HVs) were incubated with or without silica particles (25 or 50 
µg/ml) for ten days. CD69 expression in CD4+ cells was analyzed by flow cytometry. [B] 
and [C] Peripheral blood CD4+25- and CD4+25+ cell fractions derived from HVs and 
silicosis patients (SILs) were sorted by flow cytometry, extracted total RNAs from individual 
fractions, and synthesized cDNA. Real-time RT-PCR analyses were employed to compare 
the gene expression of CD69 and PD-1, respectively. [D] and [E] Serum levels of the ANA 
titer and soluble IL-2 receptor (sIL-2R), respectively, were measured by ELISA methods and 
compared among HVs, SILs and patients with systemic sclerosis (SSc). In addition, after a 
numbered disease status set to 1 for HVs, 2 for SILs and 3 for SSc, correlations between 
disease status number and titers of ANA or sIL-2R were analyzed. 
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PD-1 (Hayashi, 2010). This may suggest that silica can activate both Tresp and Treg, and that 
the CD25+ fraction in SILs may include chronically activated Tresp in which surface CD25 
expression occurred continuously due to recurrent stimulation by silica (Hayashi, 2010). 
To investigate another marker of Tresp activation, we measured the serum soluble IL-2 
receptor (sIL-2R) in SILs and compared results with those obtained from HVs and patients 
with SSc, since sIL-2R is known to arise in the serum of apparently healthy individuals who 
subclinically possess neoplastic (i.e., certain lymphoid malignancies such as T cell leukemia 
and early cell leukemia), autoimmune or inflammatory diseases (Carlson, 1992; Nelson & 
Willerford, 1998; Pizzolo, 1991; Rubin & Nelson, 1990; Zerler, 1991). The high-affinity IL-2R 
is a multichain receptor which possesses at least three IL-2 binding chains: IL-2Rǂ/CD25 (55 
kDa), IL-2Rǃ/CD122 (75 kDa) and IL-2RǄ/CD132 (64 kDa). sIL-2R is the naturally occurring 
soluble form of IL-2Rǂ. For this analysis, the serum titer of anti-nuclear antigens (ANA) was 
measured in HVs, SILs and SSc using the Enzyme-Linked ImmunoSorbent Assay (ELISA)-
based MESACUP ANA TEST (MBL Co. Ltd., Nagoya, Japan), which includes several 
recombinant proteins such as RNP, SS-A/Ro, SS-B/La, Scl-70, Jo-1 and Ribosomal P in vitro 
transcribed U1 RA and CENP-B protein, and purified antigen (Sm, SS-A/Ro, Scl-70m 
Histone and DNA) (Hayashi, 2009). As shown in Fig. 2-D, the ANA titer in SSc was the 
highest among the three groups, and significantly higher than that of HVs or SILs, whereas 
the ANA titer in SILs was also significantly higher than that of HVs. In addition, if disease 
status was numbered and set to 1 for HV, 2 for SIL and 3 for SSc, a significant positive 
correlation was obtained between the serum titer of ANA and disease status. Even our 
patients did not manifest any clinical symptoms for autoimmune diseases, and SILs 
subclinically tended to present a dysregulation of autoimmunity. Following these findings, 
serum sIL-2R was also analyzed in a manner similar to that used for the serum ANA titer. 
As shown in Fig. 2-E, SSc patients showed significantly higher serum sIL-2R than HVs or 
SILs, and the level shown by SILs tended to be higher than that shown by HVs. In addition, 
a significant positive correlation was detected between serum sIL-2R and disease status. 
These results suggest that sIL-2R may be used to detect immunological alteration in SILs, 
and that Tresp in SILs is activated chronically to an unknown higher level of sIL-2R 
(Hayashi, 2009). 
4. Chronic activation of Treg by exposure to silica 
As we have investigated Tresp activation in SILs as described above, the next point of 
interest was the function and activation of Treg. It has been revealed that CD4+25+ Treg 
contribute to maintaining self-tolerance by down-regulating the immune response to self 
and non-self antigens in an antigen-non-specific manner, presumably at the T cell activation 
stage (Baecher-Allan, 2004; Bluestone & Tang, 2005; Schwartz, 2005). Elimination and/or 
reduction of CD4+25+ T cells relieves this general suppression, thereby enhancing immune 
responses to non-self Ags and eliciting autoimmune responses to certain self-antigens. 
Recent studies have shown that CD4+25+ Treg specifically express transcription factor 
Foxp3 (Baecher-Allan, 2004; Bluestone & Tang, 2005; Schwartz, 2005). Genetic anomalies in 
Foxp3 cause autoimmune and inflammatory diseases in rodents and humans by affecting 
the development and function of CD4+CD25+ Treg (Baecher-Allan, 2004; Bluestone & Tang, 
2005; Schwartz, 2005). Clinically, a deficiency in Treg function or decrease in the proportion 
of Treg has been shown to influence the pathogenesis of collagen or autoimmune diseases 
such as multiple sclerosis (O’Connor & Anderton, 2008), rheumatoid arthritis (Toh & 
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Miossec, 2007), systemic lupus erythematosus (Mudd, 2006), and pemphigus vulgaris 
(Yokoyama & Amagai, 2010). These findings at the cellular and molecular levels provide 
firm evidence that CD4+25+Foxp3+ Treg cells are an indispensable cellular constituent of 
the normal immune system, and that these cells play crucial roles in establishing and 
maintaining immunologic self-tolerance and immune homeostasis.  
As mentioned above, CD25 molecules are also expressed on non-Treg subsets such as 
antigen-activated responder/effector T cells. Therefore, Foxp3 has been utilized as a useful 
marker to identify CD25+ regulatory T cells from CD25+ activated Tresp, although several 
distinguishable markers such as CD127 and PD-1 have been utilized to distinguish Treg 
from activated CD4+CD25+ Tresp (Liu, 2006; Hartigan-O’Connor, 2007; Saresella, 2008; 
Wang, 2009). 
As described above, since the peripheral blood CD4+25+ fraction showed higher PD-1 
expression (Fig. 2-C) and several findings demonstrate the chronic and recurrent activation 
of Tresp in SILs, the peripheral CD4+25+ fraction in SILs may be contaminated by these 
activated Tresp expressing CD25 on the base of Treg (Hayashi, 2010).  
Thus, we first analyzed the function of the Treg fraction (actually, the peripheral CD4+25+ 
fraction sorted by flow cytometry in which Treg is mainly included and there is no 
availability of FoxP3-sorted cells for biological use as mentioned above) (Wu, 2006). As 
shown in Fig. 3-A, the inhibitory function of the CD4+25+ sorted fraction from SILs was 
lower than that of HVs when this fraction was added to the mixed lymphocyte culture 
(MLR) (Tresp was stimulated by irradiated allo-PBMCs) with the ratio 1:1/4 or 1:1/2, and 
tended to be lower when added with the ratio 1:1/8 or 1:1. There may be a reduced number 
of true Treg in the CD4+25+ fraction from SILs or an impaired function of true Treg (wu, 
2006). Taken together with the results of chronic and recurrent activation of Tresp in SILs 
(Hayashi, 2010; Wu, 2005), these findings support the possibility that the CD4+25+ fraction 
in SILs may include activated Tresp due to silica exposure. To examine this possibility, Treg-
specific gene expression such as FoxP3 and cytotoxic T-lymphocyte antigen 4 (CTLA-4) was 
analyzed in CD4+25- and CD4+25+ fractions derived from HVs and SILs. As shown in Fig. 
3-B and 3-C, the CD4+25+ fraction from SILs lost the dominant expression levels of both 
genes. These results suggested the CD4+25+ fraction in SILs was contaminated with 
chronically activated Tresp by exposure to silica (Hayashi, 2010; Wu, 2006). As expected and 
shown in Fig. 3-D, the percentage of the CD4+25+ fraction in peripheral lymphocytes was 
significantly smaller in HVs than SILs. Although the CD4+FoxP3+ fraction did not differ 
between HVs and SILs, the CD25+FoxP3- population was higher in SILs than HVs (Hayashi, 
2010; Wu, 2006). These analyses indicated that the CD4+25+ fractions in SILs were 
contaminated by chronically activated Tresp due to exposure to silica (Hayashi, 2010; Wu, 
2006). Although this may explain the results of reduced inhibitory function of the CD4+25+ 
fraction from SILs, there may be another possibility regarding the number of true Treg in 
SILs. Even the percentage of the CD4+FoxP3+ fraction did not differ between SILs and HVs, 
and a certain loss of Treg may occur, otherwise the reduced inhibitory function may not be 
fully explained. 
We again take an interest with the Fas/CD95 molecule. As Tresp upregulated its CD25 
expression due to chronic exposure to silica, Treg may have excess expression of Fas/CD95 
because it has been shown that Treg expresses Fas/CD95 and is more sensitive to Fas-
mediated apoptosis than Tresp (Fritzsching, 2005, 2006). To investigate this possibility, 
peripheral blood mononuclear cells from HVs and SILs were stained with CD4, CD25, 
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Fig. 3. Various examinations to recognize the effects of silica exposure on regulatory T cells 
(Treg). ＊：p<0.05, ＊＊<0.01 and ▲：0.05<p<0.1. [A] The CD4+25- and CD4+25+ fractions 
from healthy volunteers (HVs) and silicosis patients (SILs) were collected by flow cytometry. 
CD4+25- cells with or without various ratios of CD4+25+ cells, such as 1:0, 1:1/8, 1:1/4, 1:1/2 
and 1:1, were applied to a mixed lymphocyte reaction (MLR). Allogenic irradiated peripheral 
blood mononuclear cells were used as a stimulator. Graphs express suppressive properties of 
added CD4+25+ fractions. The degree to which the added CD4+25+ fraction reduced Cd4+25- 
DNA synthesis was measured by the 3H-thymidine incorporation assay. [B] and [C] Peripheral 
blood CD4+25- and CD4+25+ cell fractions derived from HVs and SILs were sorted by flow 
cytometry, extracted total RNAs from individual fractions, and synthesized cDNA. Real-time 
RT-PCR analyses were employed to compare the gene expression of FoxP3 and CTLA-4, 
respectively. [D] Peripheral blood CD4+25+ and CD4+FoxP2+ populations were compared 
between HVs and SILs. [E] and [F] Peripheral blood CD4+FoxP3+ cells derived from HVs and 
SILs were compared in regard to CD95/Fas expression by means of fluorescent intensity and 
positive cell percentage, respectively. 
CD95/Fas and FoxP3, and CD95/Fas expression (MFI) and positive cell frequency were 
analyzed in the CD4+FoxP3+ cell fraction. As shown in Fig. 3-E (MFI) and 3-F (positive cell 
frequency), Treg from SILs showed significantly higher expression levels of CD95/Fas than 
those from HVs. In addition, CD4+25+ cells from SILs were significantly more sensitive 
against Fas-mediated apoptosis inducing monoclonal antibody (CH-11) than those from 
HVs (data not shown), and proceeded faster to apoptosis as previously reported (Hayashi, 
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2010). All of these findings indicate that Treg may lose its true Treg ability due to chronic 
activation of Treg by recurrent exposure to silica mediated by excess expression of 
Fas/CD95 on the Treg cell surface. 
5. Silica-induced dysfunction of the Treg fraction in SILs 
Our results and those of our previous findings suggest that silica can reconstitute the 
peripheral CD4+CD25+ fraction to facilitate a decline in the number and function of Treg by 
the activation of both Tresp and Treg cells (Hayashi, 2010; Maeda, 2010), as outlined in Fig. 4. 
 
 
Fig. 4. Schematic representation of the immunological effects of silica exposure on alteration 
of autoimmunity. Silica chronically activates CD4+FoxP3 T cells (Treg), resulting in the 
induction of higher Fas expression. This up-regulated Fas marks Treg for Fas-mediated 
apoptosis. However, silica induces the change of CD4+FoxP3- T cells (Tresp) to 
CD4+25+FoxP3- activated Tresp. This population contaminates the peripheral CD4+25+ 
fraction in which Treg should be located. This imbalance between a decreased Treg and 
increased activated Tresp results in a dysfunction of the so-called CD4+25+ Treg fraction, 
which may trigger the occurrence of autoimmune diseases such as SSc. However, the roles 
and alterations of Th17 in silica-exposed patients are unknown and should be clarified 
through further research in order to obtain a better understanding of the immunological 
effects of silica on the human immune system. 
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Many issues remain to be resolved, such as delineating the complications of SSc in SILs 
(Barnadas, 1986; Cowie, 1987 Haustein, 1990; Haustein & Anderegg, 1998; Sluis-Cremer, 
1985), or those complications associated with malignant tumors such as mesothelioma and 
lung cancer in patients exposed to the mineral silicate asbestos (Greillier, 2008; Toyokuni, 
2009; Miura, 2008). Regarding the relationship between tumor immunity and Treg function, 
it may be that Treg enhances cell numbers or function to reduce tumor immunity 
(Chattopadhyay, 2005; Danese & Rutella, 2007; Kretschmer, 2006). If this is the case, future 
investigations will need to determine whether silica and asbestos possess opposite effects on 
Treg. Furthermore, specific parameters will need to be examined such as the degree of silica 
exposure, the progression of respiratory diseases (Otsuki, 1999), and identification of a 
possible individual factor such as the HLA type (A. Ueki, 2001b) that leads to the 
development of autoimmune complications in SILs. 
In addition, the recent discovery of T helper type 17 cells (Th17) has contributed to the 
recognition of the occurrence of autoimmunity (Afzali, 2007; Awasthi & Kuchroo, 2009; 
Harrington, 2006; Jin, 2008; Louten, 2009; Stockinger, 2007). Research on the biology of Th17 
cells suggests a critical role for Th17 in the development of inflammatory and autoimmune 
diseases. Furthermore, Th17 has been shown to interact with Treg cells (Afzali, 2007; 
Awasthi & Kuchroo, 2009; Harrington, 2006; Jin, 2008; Louten, 2009; Stockinger, 2007). TGF-
ǃ not only regulates the generation of Foxp3+ Treg cells, but together with IL-6 initiates 
Th17 differentiation. A reciprocal relationship between Th17 and Treg development has 
been proposed, since the generation of Foxp3+ Treg cells and Th17 cells both require TGF-ǃ 
signaling. If the frequencies of Th17 and Treg were regulated by each other, silica-induced 
early loss of Treg may have an inverse effect by increasing the Th17 population, and 
represents another way to induce dysregulation of autoimmunity in SILs. Although we have 
just begun to investigate the status of Th17 in SILs, this is another important and critical 
issue to be resolved for a better understanding of environmental disturbance of 
autoimmunity such as that involving silica-induced autoimmune diseases (Shanklin & 
Smalley, 1998; Steenland & Goldsmith, 1995; Uber & McReynolds, 1982). 
In the future, a comprehensive understanding of the immunological effects of silica may 
lead to the discovery of preventive and therapeutic molecular targets for autoimmune 
diseases, and will help to clarify the pathophysiological mechanisms involved in the 
development of dysregulation of autoimmunity. 
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